Shuzhe Xiao
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Interleukin-6 in complications of prematurity: from biomarker to targeted therapy.
Journal: Frontiers in pediatrics
Published: February 26, 2026
Emerging therapeutic potential of umbilical cord-derived extracellular vesicles in lung-injurious diseases: a review of recent advances.
Journal: Stem cell research & therapy
Published: November 01, 2025
Antimicrobial peptide LL37 ameliorated experimental inflammation induced neonatal lung injury through macrophage immunomodulation.
Journal: Pediatrics and neonatology
Published: September 13, 2025
Interleukin Family-Based Signature Relates to Cancer-Associated Fibroblasts Spatial Distribution and Immune Therapy Response in Pancreatic Carcinoma.
Journal: Journal of inflammation research
Published: May 02, 2025
Analysis and Validation of Autophagy-Related Gene Biomarkers and Immune Cell Infiltration Characteristic in Bronchopulmonary Dysplasia by Integrating Bioinformatics and Machine Learning.
Journal: Journal of inflammation research
Published: September 07, 2024
Association of the national level of human development with the incidence and mortality of congenital birth defects in 2019: A cross-sectional study from 189 countries.
Journal: Bioscience trends
Published: August 28, 2024
WNT2B high‑expressed fibroblasts induce the fibrosis of IBD by promoting NK cells secreting IL-33.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: December 29, 2023
LRP1B is a Potential Biomarker for Tumor Immunogenicity and Prognosis of HCC Patients Receiving ICI Treatment.
Journal: Journal of hepatocellular carcinoma
Published: November 11, 2021
Efficacy and safety of lenvatinib monotreatment and lenvatinib-based combination therapy for patients with unresectable hepatocellular carcinoma: a retrospective, real-world study in China.
Journal: Cancer cell international
Published: May 24, 2021
Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Breast Cancer Diagnosis.
Journal: OncoTargets and therapy
Published: December 24, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026